Position in UTHR
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$5,960
+$1,810 QoQ
Shares Held
11
+57.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#813
of 870 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cromwell Holdings LLC holds $298,057 across 8 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,319 | $112,447 | |
| 2 | HLN |
Haleon plc
|
7,663 | $71,495 | |
| 3 | VTRS |
Viatris Inc
|
3,561 | $56,548 | |
| 4 | ZTS |
Zoetis Inc.
|
596 | $42,828 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
11 | $5,960 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
27 | $4,550 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
163 | $4,011 | |
| 8 | PRGO |
PERRIGO Co plc
|
21 | $218 |
All Filings in UTHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,960 | 11 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $4,150 | 7 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,923 | 6 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,515 | 6 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,724 | 6 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $616 | 2 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||